You are here

  • Home
  • Archive
  • Volume 20, Issue 7
  • Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer that Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer that Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 2019800
Feb 20191600
Mar 20193201
Apr 20191202
May 20191400
Jun 2019500
Jul 20192101
Aug 20191200
Sep 2019800
Oct 2019801
Nov 2019600
Dec 2019800
Jan 20201200
Feb 2020801
Mar 2020200
Apr 20201900
May 20202800
Jun 20204100
Jul 20202001
Aug 20206000
Sep 20201602
Oct 20201001
Nov 2020600
Dec 2020600
Jan 20211701
Feb 20211400
Mar 2021400
Apr 2021600
May 2021100
Aug 2021100
Oct 20211600
Nov 20212602
Dec 20213601
Jan 20225002
Feb 20222300
Mar 20225103
Apr 20224800
May 20225702
Jun 20227000
Jul 20223401
Aug 20227601
Sep 20225601
Oct 20226601
Nov 20223801
Dec 20223402
Jan 20232603
Feb 20236200
Mar 20234800
Apr 20233502
May 20234602
Jun 20236404
Jul 20237000
Aug 20234800
Sep 20233702
Oct 20232000
Nov 20232300
Dec 20232900
Jan 20241400
Feb 20243601
Mar 20242800
Apr 20245402
Total1742044